Replies to post #9096 on Innovus Pharmaceuticals Inc. (fka INNV)

[TrueTrades]

how do you know?
it did not happen in the 1st q!
it will be there in aug
where is the breakdown in the cso?
they list all accounts as net
big red flag
what were the gross sales?
if net sales is 2,177,290 based on cogs of 440,476 there is something criminally wrong!
what is the sales discounts and returns?
no contra account data so we will never know
I bet gross sales were 3,800,000 and giveaway sales discounts to large retailers and +40% return rate combined with 48% marketing costs is responsible for these horrid figures
innv qualifies as a bonafide scam at this point and will be treated as such
can you not read this mess?

Consolidated Statements of Operations  
                                                 (Unaudited)  
                                                   For the  
                                             Three Months Ended  
                                                  March 31,  
                                        -----------------------------  
                                            2017           2016  
                                         -----------    ----------  
 Net revenue:  
    Product sales, net                  $  2,177,290   $   224,463  
    License revenue                                -         1,000  
                                         -----------    ----------  
 Net revenue                               2,177,290       225,463  
                                         -----------    ----------  
   
 Operating expense:  
    Cost of product sales                    440,476       120,123  
    Research and development                   3,183             -  
    Sales and marketing                    1,687,351        35,496  
    General and administrative             1,704,663     1,287,737  
                                         -----------    ----------  
 Total operating expense                   3,835,673     1,443,356  
                                         -----------    ----------  
   
 Loss from operations                     (1,658,383)   (1,217,893)  
                                         -----------    ----------  
   
 Other income and (expense):  
    Interest expense                        (557,479)     (390,851)  
    Loss on extinguishment of debt          (304,828)            -  
    Other income (expense), net                 (616)        1,765  
    Fair value adjustment for  
     contingent consideration                 27,175        (5,584)  
    Change in fair value of derivative  
     liabilities                             (51,656)       57,594  
                                         -----------    ----------  
 Total other expense, net                   (887,404)     (337,076)  
                                         -----------    ----------  
   
 Net loss                               $ (2,545,787)  $(1,554,969)  
                                         ===========    ==========  
   
 Net loss per share of common stock --  
  basic and diluted                     $      (0.02)  $     (0.02)  
                                         ===========    ==========  
   
 Weighted average number of shares of  
  common stock outstanding -- basic  
  and diluted                            135,099,173    68,373,226  
                                         ===========    ========== 

and mind you it is based on 135m o/s
wait until next quarter when its based on 165m
that (.02)/sh will look even better!
sure they will spin that as positive
especially after a r/s when it shows positive eps
and shareholder deficit is $65m
just start selling rose colored glasses i guess!